Skip to main content

Table 2 Performance of BD rapid test compared with rRT-PCR test for nasal swabs in Kenya, July 2013–July 2014 (N = 3,199)

From: Evaluation of the point-of-care Becton Dickinson Veritor™ Rapid influenza diagnostic test in Kenya, 2013–2014

Characteristic

Specimens

%Sensitivity

%Specificity

%PPV

%NPV

n,

%positive

(CI, 95%)

(CI, 95%)

(CI, 95%)

(CI, 95%)

Influenza Type

 Influenza A or B

321

10.0

77.0 (72.6–80.9)

94.9 (94.0–95.7)

69.5 (65.0–73.6)

96.5 (95.7–97.1)

 Influenza A

270

8.4

77.8 (73.0–82.0)

95.8 (94.4–96.0)

66.5 (61.7–71.0)

97.2 (96.5–97.8)

 Influenza B

46

1.4

63.9 (51.7–74.6)

99.6 (99.3–99.8)

79.3 (66.3–88.4)

99.2 (98.9–99.4)

Case Type:

 SARI (n = 2059)

178

8.6

74.2 (68.1–79.5)

94.9 (93.7–95.8)

65.7 (59.7–71.3)

96.5 (95.6–97.3)

 ILI (n = 1140)

143

12.5

80.8 (73.4–82.4)

95.0 (94.4–96.0)

74.9 (61.5–70.9)

96.4 (96.7–97.9)

Department:

 Inpatienta (n = 1480)

122

8.2

76.3 (69.3–82.8)

95.2 (93.9–96.3)

65.9 (58.9–72.7)

97.1 (96.0–97.9)

 Outpatient (n = 498)

80

16.1

87.0 (77.9–92.8)

95.6 (93.0–97.3)

81.6 (72.3–88.5)

97.0 (94.7–98.4)

Age:

 < 5 years (n = 2512)

237

9.4

78.0 (72.8–82.4)

95.1 (94.1–96.0)

68.7 (63.5–73.5)

96.9 (96.1–97.6)

 ≥ 5 years (n = 687)

84

12.2

74.3 (65.1–81.9)

94.3 (91.9–96.0)

71.8 (62.6–79.5)

94.9 (92.7–96.5)

Illness onset to sample collection:

 Less than 2 days (n = 346)

23

6.6

65.7 (47.7–80.3)

92.0 (88.2–94.6)

47.9 (33.5–62.6)

96.0 (92.9–97.8)

 ≥ 2 to 3 days (n = 1267)

145

11.4

79.2 (75.5–84.7)

95.5 (94.0–96.6)

74.7 (67.9–80.6)

96.5 (95.1–97.4)

 > 3 to 4 days (n = 454)

44

9.7

80.0 (66.7–89.1)

94.5 (91.6–96.4)

66.7 (53.9–77.5)

97.2 (94.8–98.5)

 > 4 to 5 days (n = 337)

30

8.9

75.0 (58.5–86.8)

96.0 (92.9–97.8)

71.4 (55.2–83.8)

96.6 (93.7–98.3)

 > 5 to 6 days (n = 237)

21

8.9

77.8 (57.3–90.6)

95.2 (91.2–97.6)

67.7 (48.5–82.7)

97.1 (93.5–98.8)

 > 6 to 7 days (n = 174)

18

10.3

69.2 (48.1–84.9)

93.9 (88.4–97.0)

66.7 (46.0–82.8)

94.6 (89.2–97.4)

 > 7 days (n = 298)

23

7.7

76.7 (57.3–89.4)

95.9 (92.6–97.8)

67.6 (49.4–82.0)

97.3 (94.4–98.8)

 ≤ 7 days (n = 2727)

280

10.3

77.6 (72.8–81.7)

94.9 (93.9–95.7)

69.8 (65.0–74.2)

96.5 (95.7–97.2)

Sample collection to sample testingb:

 > 7 days (n = 2834)

305

10.8

76.3 (71.9–80.4)

95.2 (94.3–96.0)

72.4 (67.9–76.6)

96.1 (95.2–96.8)

 ≤ 7 days (n = 365)

16

4.4

94.1 (69.2–99.7)

92.8 (89.4–95.2)

39.0 (24.6–55.5)

99.7 (98.0–100)

Influenza Prevalence

 Influenza activity <5% (n = 640)

13

2.0

72.2 (46.4–89.3)

95.7 (93.7–97.1)

32.5 (19.1–49.2)

99.2 (98.0–99.7)

 Influenza activity 5to10% (n = 875)

42

4.8

76.4 (62.7–86.3)

95.0 (93.2–96.3)

50.6 (39.5–61.7)

98.4 (97.2–99.1)

 Influenza activity >10to15% (n = 354)

28

7.9

71.8 (54.9–84.5)

95.2 (92.1–97.2)

65.1 (49.0–78.5)

96.5 (93.6–98.1)

 Influenza activity >15% (n = 1334)

238

17.9

78.1 (73.0–82.5)

94.4 (92.7–95.7)

80.5 (75.4–84.7)

93.5 (91.8–94.9)

 Influenza activity ≥10%(n = 1684)

266

15.8

77.3 (72.5–81.6)

94.6 (93.2–95.7)

78.5 (73.6–82.6)

94.2 (92.8–95.4)

 Flu activity <10% (n = 1515)

56

3.6

75.3 (63.6–84.4)

95.3 (94.0–96.3)

44.7 (35.8–53.9)

98.7 (97.9–99.2)

Surveillance Site:

 Kibera (n = 722)

85

11.8

73.9 (64.7–81.5)

95.6 (93.5–99.7)

75.9 (66.7–83.3)

95.1 (93.1–96.6)

 Lwak (n = 499)

34

6.8

68.0 (53.2–80.1)

92.7 (89.7–94.8)

50.7 (38.4–63.0)

96.3 (94.0–97.8)

 Mombasa (595)

55

9.2

79.7 (68.0–88.1)

95.1 (92.7–96.7)

67.9 (56.5–77.6)

97.3 (95.4–98.4)

 Nakuru(874)

110

12.6

84.6 (77.0–90.1)

94.0 (91.9–95.5)

71.0 (63.0–77.8)

97.2 (95.7–98.3)

 Nyeri (n = 509)

37

7.3

69.8 (55.5–81.3)

97.8 (95.9–98.9)

78.7 (63.9–88.8)

96.5 (94.3–97.9)

  1. ILI influenza like illness, SARI Severe acute respiratory illness
  2. a In-Patients patients who had SARI and were exclusively admitted in the wards
  3. b Time to sample tested refer to the rRT-PCR only since all RIDT was performed at bedside
  4. PPV positive predictive value
  5. NPV negative predictive value
  6. CI Confidence interval